Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update

Go back to Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update
Corcept Therapeutics, Inc. (NASDAQ: CORT) Delayed: 114.86 +3.05 (2.73%)
Previous Close $111.81    52 Week High $10.00 
Open $113.18    52 Week Low $3.22 
Day High $115.09    P/E N/A 
Day Low $111.07    EPS $-0.46 
Volume 883,640